Literature DB >> 22590939

[Dexmedetomidine for postoperative sedation in elderly patients with cognitive impairment].

Mikiko Ohtsuka1.   

Abstract

BACKGROUND: Dexmedetomidine (DEX) has analgesic, anxiolytic, and antidelirium effects, and causes little respiratory depression. Behavioral disturbances such as agitation, aggression, and sleep disorder are common in cognitive impairment; this impairment may be one of the risk factors for postoperative delirium. We studied the effects of postoperative DEX administration in elderly patients with cognitive impairment.
METHODS: Ten patients with cognitive impairment, aged 70 to 90 years, were maintained under both general and local anesthesia. We administered DEX (0.2-0.4 microg x kg(-1) x hr(-1)) to these patients 30 to 60 min before the end of the operation. The dose of DEX was reduced to 0.1-0.2 microg x kg(-1) hr(-1) by the time of extubation, and was increased in incremental doses 0.1 microg x kg(-1) x hr(-1) depending on postoperative agitation.
RESULTS: Seven of 10 patients were calm; however, in 3 patients, the dose had to be increased by 0.1 microg x kg(-1) x hr(-1). No serious complication was observed, except bradycardia in 2 patients.
CONCLUSIONS: Low-dose DEX is safe and useful for postoperative sedation in elderly patients with cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22590939

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  3 in total

1.  Beneficial effects of dexmedetomidine on early postoperative cognitive dysfunction in pediatric patients with tonsillectomy.

Authors:  Chuanlai Han; Rong Fu; Weifu Lei
Journal:  Exp Ther Med       Date:  2018-05-17       Impact factor: 2.447

Review 2.  Neurocognitive dysfunction risk alleviation with the use of dexmedetomidine in perioperative conditions or as ICU sedation: a meta-analysis.

Authors:  Bo Li; Huixia Wang; Hui Wu; Chengjie Gao
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

3.  The effect of intraoperative dexmedetomidine on cognitive dysfunction after surgery: a updated meta-analysis.

Authors:  Jianli Li; Qifan Yin; Xuejiao Xun; Jinhua He; Dongdong Yu; Zhibin Wang; Junfang Rong
Journal:  J Cardiothorac Surg       Date:  2021-12-14       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.